174 related articles for article (PubMed ID: 30643205)
41. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting.
Dasgupta A; Tinch S; Szczur K; Ernst R; Shryock N; Kaylor C; Lewis K; Day E; Truong T; Swaney W
Methods Mol Biol; 2020; 2086():27-60. PubMed ID: 31707666
[TBL] [Abstract][Full Text] [Related]
42. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
[TBL] [Abstract][Full Text] [Related]
43. Using Pulmozyme DNase treatment in lentiviral vector production.
Shaw A; Bischof D; Jasti A; Ernstberger A; Hawkins T; Cornetta K
Hum Gene Ther Methods; 2012 Feb; 23(1):65-71. PubMed ID: 22428981
[TBL] [Abstract][Full Text] [Related]
44. Creating higher titer lentivirus with caffeine.
Ellis BL; Potts PR; Porteus MH
Hum Gene Ther; 2011 Jan; 22(1):93-100. PubMed ID: 20626321
[TBL] [Abstract][Full Text] [Related]
45. Reliable RT-qPCR-based titration of retroviral and lentiviral vectors via quantification of residual vector plasmid DNA in samples.
Jang YH; Song HI; Yang Y; Lim KI
Biotechnol Lett; 2016 Aug; 38(8):1285-91. PubMed ID: 27146205
[TBL] [Abstract][Full Text] [Related]
46. Production of lentiviral vectors in protein-free media.
Kuroda H; Marino MP; Kutner RH; Reiser J
Curr Protoc Cell Biol; 2011 Mar; Chapter 26():Unit 26.8. PubMed ID: 21400699
[TBL] [Abstract][Full Text] [Related]
47. [Construction and identification of mouse BTLA lentiviral expression vector].
Zeng J; Bao J; Wang H; Zhang H; Zhang J; Wang W; Guan X; Xu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):261-4. PubMed ID: 23643082
[TBL] [Abstract][Full Text] [Related]
48. Genome editing for scalable production of alloantigen-free lentiviral vectors for
Milani M; Annoni A; Bartolaccini S; Biffi M; Russo F; Di Tomaso T; Raimondi A; Lengler J; Holmes MC; Scheiflinger F; Lombardo A; Cantore A; Naldini L
EMBO Mol Med; 2017 Nov; 9(11):1558-1573. PubMed ID: 28835507
[TBL] [Abstract][Full Text] [Related]
49. Novel bovine lentiviral vectors based on Jembrana disease virus.
Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
[TBL] [Abstract][Full Text] [Related]
50. The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology.
Luis A
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003492
[TBL] [Abstract][Full Text] [Related]
51. Lentivirus Production and Purification.
Benskey MJ; Manfredsson FP
Methods Mol Biol; 2016; 1382():107-14. PubMed ID: 26611582
[TBL] [Abstract][Full Text] [Related]
52. Stable Expression by Lentiviral Transduction of Cells.
Gödecke N; Hauser H; Wirth D
Methods Mol Biol; 2018; 1850():43-55. PubMed ID: 30242679
[TBL] [Abstract][Full Text] [Related]
53. Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice.
Gándara C; Affleck V; Stoll EA
Hum Gene Ther Methods; 2018 Feb; 29(1):1-15. PubMed ID: 29212357
[TBL] [Abstract][Full Text] [Related]
54. Improved third-generation lentiviral packaging with pLKO.1C vectors.
Lee S; Cobrinik D
Biotechniques; 2020 Jun; 68(6):349-352. PubMed ID: 32141762
[TBL] [Abstract][Full Text] [Related]
55. Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research.
Dropulić B
Hum Gene Ther; 2011 Jun; 22(6):649-57. PubMed ID: 21486177
[TBL] [Abstract][Full Text] [Related]
56. Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.
Kantor B; Bayer M; Ma H; Samulski J; Li C; McCown T; Kafri T
Mol Ther; 2011 Mar; 19(3):547-56. PubMed ID: 21157436
[TBL] [Abstract][Full Text] [Related]
57. [Preparation of lentivirus containing human FcγRIIB gene and FcγRIIB expression in HT-1080 cells].
Liu H; Cao X; Yang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):561-4, 568. PubMed ID: 24909272
[TBL] [Abstract][Full Text] [Related]
58. New developments in lentiviral vector design, production and purification.
Segura MM; Mangion M; Gaillet B; Garnier A
Expert Opin Biol Ther; 2013 Jul; 13(7):987-1011. PubMed ID: 23590247
[TBL] [Abstract][Full Text] [Related]
59. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection.
Kuroda H; Kutner RH; Bazan NG; Reiser J
J Virol Methods; 2009 May; 157(2):113-21. PubMed ID: 19114057
[TBL] [Abstract][Full Text] [Related]
60. Self-inactivating lentiviral vectors with U3 and U5 modifications.
Iwakuma T; Cui Y; Chang LJ
Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
